Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_assertion description "[In conclusion, the novel tumor suppressor FBXO32 is epigenetically silenced in ovarian cancer cell lines with disrupted TGF-beta/SMAD4 signaling, and FBXO32 methylation status predicts survival in patients with ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_assertion evidence source_evidence_literature NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_assertion SIO_000772 20065949 NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_assertion wasDerivedFrom befree-20140225 NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_assertion wasGeneratedBy ECO_0000203 NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP557523.RAz0IEy4zxCIb7dv4pcZy0vnY7tjv7JLPIHHjg88ywfZk130_provenance.